The Missing Association: Sequencing-Based Discovery of Novel SNPs in VKORC1 and CYP2C9 That Affect Warfarin Dose in African Americans
- 26 January 2011
- journal article
- Published by Wiley in Clinical Pharmacology & Therapeutics
- Vol. 89 (3), 408-415
- https://doi.org/10.1038/clpt.2010.322
Abstract
It is well recognized that the genetic variants VKORC–‐1–39, CYP2C9*2, and CYP2C9*3 contribute to warfarin dose response. This has led to warfarin dosing algorithms that include these polymorphisms and explains between 47% and 56% of variability in dose in Caucasians. However, these polymorphisms explain significantly less of the variance in dose among African Americans. In order to identify novel variations that affect warfarin dose in African Americans, we used a targeted resequencing strategy that examined evolutionarily conserved sequences and regions of putative transcriptional binding. Through ethnicity‐specific warfarin dose model building in 330 African Americans, we identified two novel genetic associations with higher warfarin dose, namely, VKORC–‐8–91 (rs61162043, P = 0.0041) and 18786 in CYP2C9 (rs7089580, P = 0.035). These novel finds are independent of the previous associations with these genes. Our regression model, encompassing both genetic and clinical variables, explained 40% of the variability in warfarin dose in African‐American subjects, significantly more than any model thus far. Clinical Pharmacology & Therapeutics (2011) 89 3, 408–415. doi:10.1038/clpt.2010.322Keywords
This publication has 40 references indexed in Scilit:
- VKORC1 polymorphisms, haplotypes and haplotype groups on warfarin dose among African–Americans and European–AmericansPharmacogenomics, 2008
- Regulatory polymorphism in vitamin K epoxide reductase complex subunit 1 (VKORC1) affects gene expression and warfarin dose requirementBlood, 2008
- Dosing Algorithms to Predict Warfarin Maintenance Dose in Caucasians and African AmericansClinical Pharmacology & Therapeutics, 2008
- Influence ofCYP2C9andVKORC1on warfarin dose, anticoagulation attainment and maintenance among European–Americans and African–AmericansPharmacogenomics, 2008
- Systematic Overview of Warfarin and Its Drug and Food InteractionsArchives of Internal Medicine, 2005
- Contribution of age, body size, and CYP2C9 genotype to anticoagulant response to warfarinClinical Pharmacology & Therapeutics, 2004
- Selecting a Maximally Informative Set of Single-Nucleotide Polymorphisms for Association Analyses Using Linkage DisequilibriumAmerican Journal of Human Genetics, 2004
- The association of vitamin K status with warfarin sensitivity at the onset of treatmentBritish Journal of Haematology, 2001
- TRANSFAC: an integrated system for gene expression regulationNucleic Acids Research, 2000
- The pharmacodynamics of the oral anticoagulant drugs.1974